Market Analysis Finds Commercial Promise for Colorectal Cancer Drug
Sapience is developing a novel peptide, beta-catenin antagonist, to treat colorectal cancer. Avi Strauss '20K, a recent graduate of the Biotechnology Management and Entrepreneurshi…
Sapience is developing a novel peptide, beta-catenin antagonist, to treat colorectal cancer. Avi Strauss '20K, a recent graduate of the Biotechnology Management and Entrepreneurshi…